GlassScriptPhysician profile
Brittany Dee Mueller
NPI 1063944650
$1,513.29
in general payments reported to CMS, 2019-2025
17 companies · $532 in 2025
The $532 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $14.40 · 2021: $210 · 2022: $142 · 2023: $234 · 2024: $381 · 2025: $532.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,147.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,147.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $390.38 | 2022-2025 | Repatha, Repatha, Otezla |
| Lilly USA, LLC | $263.87 | 2022-2025 | Mounjaro, Zepbound |
| Novo Nordisk INC | $211.02 | 2021-2025 | Wegovy, Ozempic, Rybelsus |
| Global Blood Therapeutics, INC. | $114.28 | 2021 | |
| Exact Sciences Corporation | $99.58 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Lundbeck LLC | $64.00 | 2025 | Rexulti |
| Abbvie INC. | $61.76 | 2021-2023 | |
| Glaxosmithkline, LLC. | $49.63 | 2024-2025 | Trelegy Ellipta, Shingrix |
| Dexcom, INC. | $44.55 | 2021-2022 | |
| Pfizer INC. | $43.69 | 2023-2024 | |
| Merck Sharp & Dohme LLC | $42.66 | 2020-2023 | Vaxneuvance, Gardasil 9, Pneumovax 23 |
| Bayer Healthcare Pharmaceuticals INC. | $37.15 | 2025 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $32.03 | 2025 | Caplyta |
| Phathom Pharmaceuticals, INC. | $18.19 | 2025 | Voquezna |
| Currax Pharmaceuticals LLC | $16.07 | 2024 | Contrave |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $12.59 | 2021 | |
| Janssen Pharmaceuticals, INC | $11.84 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brittany Dee Mueller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.